Chardan Capital Comments on Krystal Biotech FY2025 Earnings
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Research analysts at Chardan Capital dropped their FY2025 earnings estimates for shares of Krystal Biotech in a report issued on Tuesday, April 29th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earnings per share of $6.15 for the year, down from their prior […]
More Stories
Remote-Job Postings Rise 20 Percent Sequentially in First Quarter: Report
By Mary Prenon While many American companies, both large and small, have called employees back to the office over the...
Acting Attorney General Blanche Rejects Speculation About Bondi’s Departure
By Jack Phillips Interim Attorney General Todd Blanche dismissed speculation that Pam Bondi left her position as attorney general in...
US Fighter Jet Downed Over Iran, One Crew Member Rescued, Search Ongoing
By Tom Ozimek Search-and-rescue efforts were underway in southern Iran on April 3 after an American fighter jet was shot...
Trump Signals Possible US Operation to Reopen Strait of Hormuz
By Tom Ozimek U.S. President Donald Trump said on April 3 that the United States could “easily” reopen the Strait...
Age of Attraction Season 2? Renewal, Couples, Release Date, and Trailer
After a positive review of the debut of season 1 on March 11, 2026, people are craving more for the...
‘Bob’s Burgers’ Actor Identified as Driver Rescued From Fiery New Hampshire Crash
By Haika Mrema Actor and comedian Eugene Mirman has been identified as the driver rescued from a burning vehicle following...